Skip to main content
. 2005 Apr 7;11(13):2041–2044. doi: 10.3748/wjg.v11.i13.2041

Figure 3.

Figure 3

Liver metastasis (black arrow) visualized by whole body scanning with In-111 octreotide (octreoscan) before initiation of SR-LAN therapy (A). Octreoscan obtained after 12 mo of SR-LAN demonstrates a marked reduction in the liver uptake (B).